These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2832630)

  • 1. Potency and receptors involved in coronary vasoconstriction caused by neuropeptide Y(NPY).
    Aizawa Y; Satoh M; Aizawa M; Funazaki T; Niwano S; Miyajima S; Shibata A
    Jpn Heart J; 1987 Nov; 28(6):891-8. PubMed ID: 2832630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary vasoconstrictive effects of neuropeptide Y and their modulation by the ATP-sensitive potassium channel in anesthetized dogs.
    Tanaka E; Mori H; Chujo M; Yamakawa A; Mohammed MU; Shinozaki Y; Tobita K; Sekka T; Ito K; Nakazawa H
    J Am Coll Cardiol; 1997 May; 29(6):1380-9. PubMed ID: 9137239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y (NPY): a coronary vasoconstrictor and potentiator of catecholamine-induced coronary constriction.
    Macho P; Pérez R; Huidobro-Toro JP; Domenech RJ
    Eur J Pharmacol; 1989 Aug; 167(1):67-74. PubMed ID: 2776842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoconstrictor effect of neuropeptide Y (NPY) on canine coronary artery.
    Aizawa Y; Murata M; Hayashi M; Funazaki T; Ito S; Shibata A
    Jpn Circ J; 1985 Jun; 49(6):584-8. PubMed ID: 3839860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nifedipine on neuropeptide Y-induced coronary vasoconstriction in anesthetized dogs.
    Hayashi M; Aizawa Y; Satoh M; Suzuki K; Shibata A
    Jpn Heart J; 1986 Mar; 27(2):251-7. PubMed ID: 3755186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of the vasoconstrictor action of neuropeptide-Y by calcium-channel blockers.
    Aizawa Y; Niwano S; Aizawa M; Tamura M; Shibata A
    Angiology; 1989 Oct; 40(10):890-4. PubMed ID: 2802259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intense sympathetic stimulation releases neuropeptide Y but fails to evoke sustained coronary vasoconstriction in dogs.
    Otani N; Yang T; Levy MN
    Circ Res; 1993 Apr; 72(4):816-26. PubMed ID: 8443869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects of intracoronary neuropeptide Y in dogs: resistance to alpha adrenergic blockade.
    Stack RK; Patterson RE
    Cardiovasc Res; 1991 Sep; 25(9):757-63. PubMed ID: 1666019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmural regulation of myocardial perfusion by neuropeptide Y.
    Gutterman DD; Morgan DA
    Basic Res Cardiol; 1995; 90(4):348-55. PubMed ID: 8534260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of nicorandil on sympathetic coronary vasoconstriction.
    Chujo M; Mori H; Tanaka E; Nakazawa H; Okino H
    Cardiovasc Res; 1994 Jun; 28(6):917-22. PubMed ID: 7923299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine receptor blockade with 8-p-sulfophenyltheophylline aggravates coronary constriction.
    Martin SE; Tidmore WC; Patterson RE
    Am J Physiol; 1991 Jun; 260(6 Pt 2):H1753-9. PubMed ID: 2058714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man.
    Clarke J; Benjamin N; Larkin S; Webb D; Maseri A; Davies G
    Circulation; 1991 Mar; 83(3):774-7. PubMed ID: 1999028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary constriction due to neuropeptide Y: alleviation with cyclooxygenase blockers.
    Martin SE; Patterson RE
    Am J Physiol; 1989 Sep; 257(3 Pt 2):H927-34. PubMed ID: 2506768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide-Y. A peptide found in human coronary arteries constricts primarily small coronary arteries to produce myocardial ischemia in dogs.
    Maturi MF; Greene R; Speir E; Burrus C; Dorsey LM; Markle DR; Maxwell M; Schmidt W; Goldstein SR; Patterson RE
    J Clin Invest; 1989 Apr; 83(4):1217-24. PubMed ID: 2703530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of age and hyperlipidemia on rabbit coronary responses to neuropeptide Y and the interaction with norepinephrine.
    Corr L; Burnstock G; Poole-Wilson P
    Peptides; 1993; 14(2):359-64. PubMed ID: 8483814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation by neuropeptide Y of parasympathetic nerve-evoked nasal vasodilatation via Y2 prejunctional receptor.
    Lacroix JS; Ulman LG; Potter EK
    Br J Pharmacol; 1994 Oct; 113(2):479-84. PubMed ID: 7834199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y is a vasoconstrictor of human coronary arteries.
    Tseng CJ; Robertson D; Light RT; Atkinson JR; Robertson RM
    Am J Med Sci; 1988 Jul; 296(1):11-6. PubMed ID: 3407677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y potentiates contractile response to norepinephrine in skate coronary artery.
    Bjenning C; Holmgren S; Farrell AP
    Am J Physiol; 1993 Aug; 265(2 Pt 2):H661-5. PubMed ID: 8368368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.